In this study, GUDCA treatment prevented changes in mitochondrial dynamic properties and apoptosis by reducing caspase-9 levels, indicating its beneficial anti-apoptotic effects required to decelerate the onset and progression of ALS. Here, CASP9 is linked to amyotrophic lateral sclerosis.